Abstract: Compounds of formula wherein: r1is and R2, R4, and R6-9 are defined herein, and pharmaceutlcally acceptable salts and esters thereof. These compounds Inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this Invention are disclosed. Various compositions containing the compounds of this Invention are also disclosed.
| # | Name | Date |
|---|---|---|
| 1 | abstract.jpg | 2011-08-21 |
| 2 | 7513-del-2010-form-5.pdf | 2011-08-21 |
| 3 | 7513-del-2010-form-3.pdf | 2011-08-21 |
| 4 | 7513-del-2010-form-2.pdf | 2011-08-21 |
| 5 | 7513-del-2010-form-18.pdf | 2011-08-21 |
| 6 | 7513-del-2010-form-1.pdf | 2011-08-21 |
| 7 | 7513-del-2010-description (complete).pdf | 2011-08-21 |
| 8 | 7513-del-2010-correspondence-others.pdf | 2011-08-21 |
| 9 | 7513-del-2010-claims.pdf | 2011-08-21 |
| 10 | 7513-del-2010-assignment.pdf | 2011-08-21 |
| 11 | 7513-del-2010-abstract.pdf | 2011-08-21 |
| 12 | 7513-delnp-2010-Form-13-(13-05-2013).pdf | 2013-05-13 |
| 13 | 7513-delnp-2010-Correspondence Others-(13-05-2013).pdf | 2013-05-13 |
| 14 | 7513-delnp-2010-Claims-(13-05-2013).pdf | 2013-05-13 |
| 15 | Petition under rule 137 for filing of form 3.pdf | 2014-12-02 |
| 16 | Covering letter.pdf | 2014-12-02 |
| 17 | 7513-DELNP-2010-Power of Attorney-031214.pdf | 2014-12-12 |
| 18 | 7513-DELNP-2010-Other Patent Document-031214.pdf | 2014-12-12 |
| 19 | Form 2.pdf | 2014-12-16 |
| 20 | FEr reply.pdf | 2014-12-16 |
| 21 | Amended claims.pdf | 2014-12-16 |
| 22 | Acknowledgment receipt.pdf | 2014-12-16 |
| 23 | Abstract.pdf | 2014-12-16 |
| 24 | 7513-delnp-2010-Form-3-(15-10-2015).pdf | 2015-10-15 |
| 25 | 7513-delnp-2010-Correspondence Others-(15-10-2015).pdf | 2015-10-15 |
| 26 | 7513-DELNP-2010_EXAMREPORT.pdf | 2016-06-30 |
| 27 | 7513-DELNP-2010-HearingNoticeLetter.pdf | 2018-01-25 |
| 28 | 7513-DELNP-2010-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [08-03-2018(online)].pdf | 2018-03-08 |
| 29 | 7513-DELNP-2010-ExtendedHearingNoticeLetter_24Apr2018.pdf | 2018-03-09 |
| 30 | 7513-DELNP-2010-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [18-04-2018(online)].pdf | 2018-04-18 |
| 31 | 7513-DELNP-2010-ExtendedHearingNoticeLetter_05Jun2018.pdf | 2018-04-19 |
| 32 | 7513-DELNP-2010-Written submissions and relevant documents (MANDATORY) [19-06-2018(online)].pdf | 2018-06-19 |
| 33 | 7513-DELNP-2010-FORM-26 [19-06-2018(online)].pdf | 2018-06-19 |
| 34 | 7513-DELNP-2010-PatentCertificate02-07-2018.pdf | 2018-07-02 |
| 35 | 7513-DELNP-2010-IntimationOfGrant02-07-2018.pdf | 2018-07-02 |
| 36 | 7513-DELNP-2010-RELEVANT DOCUMENTS [11-02-2019(online)].pdf | 2019-02-11 |
| 37 | 7513-DELNP-2010-RELEVANT DOCUMENTS [30-03-2020(online)].pdf | 2020-03-30 |
| 38 | 7513-DELNP-2010-FORM-26 [16-07-2020(online)].pdf | 2020-07-16 |
| 39 | 7513-DELNP-2010-RELEVANT DOCUMENTS [20-08-2021(online)].pdf | 2021-08-20 |
| 40 | 7513-DELNP-2010-RELEVANT DOCUMENTS [27-05-2022(online)].pdf | 2022-05-27 |
| 41 | 7513-DELNP-2010-RELEVANT DOCUMENTS [01-06-2022(online)].pdf | 2022-06-01 |
| 42 | 7513-DELNP-2010-FORM-26 [06-07-2022(online)].pdf | 2022-07-06 |
| 43 | 7513-DELNP-2010-RELEVANT DOCUMENTS [27-06-2023(online)].pdf | 2023-06-27 |
| 44 | 7513-DELNP-2010-RELEVANT DOCUMENTS [28-06-2023(online)].pdf | 2023-06-28 |